Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.
|
J Am Acad Dermatol
|
2002
|
2.41
|
2
|
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
|
Pediatrics
|
2002
|
1.22
|
3
|
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
|
J Am Acad Dermatol
|
2007
|
1.15
|
4
|
A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
|
Cutis
|
2009
|
1.11
|
5
|
Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.
|
J Am Acad Dermatol
|
2006
|
0.92
|
6
|
Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.
|
J Drugs Dermatol
|
2007
|
0.87
|
7
|
The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.
|
Cutis
|
2005
|
0.86
|
8
|
Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
|
J Drugs Dermatol
|
2007
|
0.83
|
9
|
Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.
|
J Drugs Dermatol
|
2010
|
0.83
|
10
|
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
|
Cutis
|
2004
|
0.79
|
11
|
An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion.
|
Acta Derm Venereol
|
2003
|
0.79
|
12
|
Long-term safety and efficacy study of adapalene 0.3% gel.
|
J Drugs Dermatol
|
2008
|
0.78
|
13
|
Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
|
J Drugs Dermatol
|
2010
|
0.77
|